Back
Avid Bioservices 10K Form
Buy
63
CDMO
Avid Bioservices
Last Price:
12.29
Seasonality Move:
79.8%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CDMO News And Ratings
See the #1 stock for the next 7 days that we like better than CDMO
CDMO Financial Statistics
Sales & Book Value
| Annual Sales: | $139.91M |
|---|---|
| Cash Flow: | $-4.99M |
| Price / Cash Flow: | 0 |
| Annual Sales: | $0.92 |
| Price / Book: | 13.23 |
Profitability
| EPS (TTM): | -2.27000 |
|---|---|
| Net Income (TTM): | $-144.17M |
| Gross Margin: | $7.32M |
| Return on Equity: | -106.95% |
| Return on Assets: | -35.62% |
Avid Bioservices Earnings Forecast
Key Avid Bioservices Financial Ratios
- The Gross Profit Margin over the past 30 years for CDMO is 5.23%.
- The Selling, General & Administrative Expenses for CDMO have been equal to 18.58% of Gross Profit Margin.
- The Research & Development expenses have been 49.11% of Revenue.
- The Interest Expense is -3.08% of Operating Income.
- The Net Earning history of CDMO is -100.60% of Total Revenues.
- Per Share Earnings over the last 30 years have been positive in 19 years.
Avid Bioservices Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CDMO |
| CUSIP: | 05368M |
| Website: | avidbio.com |
Debt
| Debt-to-Equity Ratio: | 2.62 |
|---|---|
| Current Ratio: | 1.46 |
| Quick Ratio: | 0.96 |
Price-to-Earnings
| Trailing P/E Ratio: | 0 |
|---|---|
| Forward P/E Ratio: | 192.01 |
CDMO Technical Analysis vs Fundamental Analysis
Buy
63
Avid Bioservices (CDMO)
is a Buy
Is Avid Bioservices a Buy or a Sell?
-
Avid Bioservices stock is rated a Buy
The current Avid Bioservices [CDMO] share price is $12.22. The Score for CDMO is 63, which is 26% above its historic median score of 50, and infers lower risk than normal.